WSC
TEVA icon

Wellington Shields & Co’s Teva Pharmaceuticals TEVA Stock Holding History

Wellington Shields & Co’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Sell
34,305
-8
-0% -$266 0.26% 90
2026
Q1 		$1.03M Buy
34,313
+13
+0% +$418 0.26% 89
2025
Q4 		$1.07M Hold
34,300
– – 0.26% 82
2025
Q3 		$693K Hold
34,300
– – 0.18% 113
2025
Q2 		$575K Sell
34,300
-2,000
-6% -$32.3K 0.16% 123
2025
Q1 		$558K Buy
+36,300
New +$648K 0.17% 123

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Wellington Shields & Co's TEVA Position: Q2 2026 in Review

Wellington Shields & Co reduced its Teva Pharmaceuticals (TEVA) stake by 0.02% in Q2 2026, selling an estimated $266 and leaving 34,305 shares worth $1.16M. The position accounts for 0.26% of the portfolio, ranked #90.

Wellington Shields & Co first reported a position in TEVA in Q1 2025 and has held it in 6 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Wellington Shields & Co held 34,305 shares of Teva Pharmaceuticals worth $1.16M as of Q2 2026.
  • Wellington Shields & Co sold 8 Teva Pharmaceuticals shares in Q2 2026, an estimated $266.
  • Teva Pharmaceuticals made up 0.26% of Wellington Shields & Co's portfolio in Q2 2026, its #90 holding.
  • Wellington Shields & Co first reported a position in Teva Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Wellington Shields & Co's 13F filing for Q2 2026, filed 10 Aug 2026.